| Outcome Measures: |
Primary: Digoxin Cmax (Maximum Observed Plasma Concentration), Blood samples for pharmacokinetic parameters were drawn at pre-dose and at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, and 120 h after administration of digoxin, Up to 120 hours|Digoxin Tmax (Time of Maximum Observed Plasma Concentration), Blood samples for pharmacokinetic parameters were drawn at pre-dose and at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, and 120 h after administration of digoxin, Up to 120 hours|Digoxin T1/2 (Apparent Terminal Elimination Half-life), Blood samples for pharmacokinetic parameters were drawn at pre-dose and at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, and 120 h after administration of digoxin, Up to 120 hours|AUC0-inf (Area Under the Plasma Concentration-time Curve From Time 0 to Infinity), Blood samples for pharmacokinetic parameters were drawn at pre-dose and at 0.5, 1, 1.5, 2, 3, 4, 6, 8, 12, 24, 48, 72, 96, and 120 h after administration of digoxin, Up to 120 hours |
|
